0001140361-16-060226.txt : 20160405 0001140361-16-060226.hdr.sgml : 20160405 20160405153309 ACCESSION NUMBER: 0001140361-16-060226 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160404 FILED AS OF DATE: 20160405 DATE AS OF CHANGE: 20160405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kramer Robert CENTRAL INDEX KEY: 0001380956 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 161554260 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 doc1.xml FORM 4 X0306 4 2016-04-04 0 0001367644 Emergent BioSolutions Inc. EBS 0001380956 Kramer Robert 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 0 1 0 0 EVP, Corporate Services Divisi Common Stock 2016-04-04 4 M 0 5766 14.41 A 80597 D Common Stock 2016-04-04 4 S 0 5766 36.90 D 74831 D Common Stock 2016-04-04 4 M 0 1970 14.67 A 76801 D Common Stock 2016-04-04 4 S 0 1970 36.90 D 74831 D Common Stock 2016-04-04 4 M 0 8677 28.09 A 83508 D Common Stock 2016-04-04 4 S 0 8677 36.90 D 74831 D Common Stock 2016-04-04 4 M 0 2752 29 A 77583 D Common Stock 2016-04-04 4 S 0 2752 36.90 D 74831 D Common Stock 2016-04-04 4 S 0 2623 36.90 D 72208 D Common Stock 2016-03-11 4 F 0 422 34.22 D 71786 D Stock Option 14.41 2016-04-04 4 M 0 5766 0 A 2019-11-04 Common Stock 5766 5765 D Stock Option 14.67 2016-04-04 4 M 0 1970 0 A 2020-03-11 Common Stock 1970 1970 D Stock Option 28.09 2016-04-04 4 M 0 8677 0 A 2021-03-10 Common Stock 8677 26031 D Stock Option 29 2016-04-04 4 M 0 2752 0 A 2022-03-09 Common Stock 2752 24762 D Consists of an option granted under the company's stock incentive plan on November 5, 2012. Consists of an option granted under the company's stock incentive plan on March 12, 2013. Consists of an option granted under the company's stock incentive plan on March 11, 2014. Consists of an option granted under the company's stock incentive plan on March 10, 2015. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kramer. Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. The option vested in three equal installments in November 2013, 2014 and 2015. The option vest in three equal installments in March 2014, 2015 and 2016. The option vest in three equal installments in March 2015, 2016 and 2017. The option vest in three equal installments in March 2016, 2017 and 2018. /s/ Eric Burt, attorney-in-fact 2016-04-05